Rapid Pancreatic and Ovarian Screening MR Imaging With Motion Corrected T1, T2, and Advanced Diffusion Weighted Imaging for Patients With BRCA Mutation Who Undergo Screening Breast MRI
| Status: | Recruiting |
|---|---|
| Conditions: | Obesity Weight Loss |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 30 - Any |
| Updated: | 9/28/2018 |
| Start Date: | June 2015 |
| End Date: | June 2019 |
| Contact: | Peter Sawan, MD |
| Email: | sawanp@mskcc.org |
| Phone: | 212-639-7121 |
Pilot Study Pancreatic and Ovarian Screening MR Imaging of Rapid With Motion Corrected T1, T2, and Advanced Diffusion Weighted Imaging for Patients With BRCA Mutation Who Undergo Screening Breast MRI
The purpose of this study is to create a rapid scan of the pancreas and ovaries that could be
used in the future to screen patients at risk for pancreatic or ovarian cancers. Currently,
Magnetic Resonance Imaging (MRI) examinations of the pancreas and ovaries can last 30-45
minutes each. The investigators hope to create a rapid pancreatic and ovarian MRI evaluation
that can be used as a screening tool that is completed in approximately 15 minutes. They will
compare different tools available on modern MRI scanners to see which one reliably offers
high quality images of the pancreas and ovaries.
used in the future to screen patients at risk for pancreatic or ovarian cancers. Currently,
Magnetic Resonance Imaging (MRI) examinations of the pancreas and ovaries can last 30-45
minutes each. The investigators hope to create a rapid pancreatic and ovarian MRI evaluation
that can be used as a screening tool that is completed in approximately 15 minutes. They will
compare different tools available on modern MRI scanners to see which one reliably offers
high quality images of the pancreas and ovaries.
Inclusion Criteria:
- BRCA 1 or 2 mutation
- Age ≥ 30
- Patients scheduled to undergo screening breast MRI with contrast
Exclusion Criteria:
- Patients with known breast cancer
- Patients unable to complete their scheduled breast MRI
- Patients with prior pancreatic surgery or cancers
- Patients with prior ovarian cancer or surgery involving removal of one or both ovaries
- Patients with prior abdominal or pelvic surgery
We found this trial at
1
site
1275 York Ave
New York, New York 10021
New York, New York 10021
(212) 639-2000
Phone: 212-639-7121
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
Click here to add this to my saved trials
